These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3015408)

  • 1. Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.
    Ball ED; Nichols KE; Pettengill OS; Sorenson GD; Fanger MW
    Cancer Immunol Immunother; 1986; 22(3):211-6. PubMed ID: 3015408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of small cell carcinoma of the lung (SCCL) cells by cytokine-activated monocytes and natural killer cells in the presence of bispecific immunoconjugates containing a gastrin-releasing peptide (GRP) analog or a GRP antagonist.
    Chen J; Zhou JH; Mokotoff M; Fanger MW; Ball ED
    J Hematother; 1995 Oct; 4(5):369-76. PubMed ID: 8581371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
    Ball ED; Sorenson GD; Pettengill OS
    Cancer Res; 1986 May; 46(5):2335-9. PubMed ID: 3008987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K; Platsoucas CD; Balch CM
    Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity to peripheral blood lymphocytes and low HLA-class I antigen expression of small cell lung cancer cell lines with diverse chemo-radiosensitivity.
    Tanio Y; Watanabe M; Osaki T; Tachibana I; Kawase I; Kuritani T; Saito S; Masuno T; Kodama N; Furuse K
    Jpn J Cancer Res; 1992 Jul; 83(7):736-45. PubMed ID: 1325431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of beta- and gamma-interferons on natural killer cell-mediated lysis of lung carcinoma cells.
    Krishnamurti C; Ahrens P; Ankel H
    Immunobiology; 1987 Mar; 174(2):221-32. PubMed ID: 3110053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK; Djeu JY
    J Immunol; 1988 Dec; 141(11):4067-73. PubMed ID: 2460557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
    Stötter H; Wiebke EA; Tomita S; Belldegrun A; Topalian S; Rosenberg SA; Lotze MT
    J Immunol; 1989 Mar; 142(5):1767-73. PubMed ID: 2493053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells.
    Shimazaki C; Atzpodien J; Wisniewski D; Gulati SC; Kolitz JE; Fried J; Clarkson BD
    Acta Haematol; 1988; 80(4):203-9. PubMed ID: 3146198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of keratinocytes by IL-2-activated peripheral blood lymphocytes.
    Symington FW; Santos EB
    J Invest Dermatol; 1991 Jan; 96(1):127-33. PubMed ID: 1987288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity.
    Toledano M; Mathiot C; Michon J; Andreu G; Lando D; Brandely M; Fridman WH
    Cancer Immunol Immunother; 1989; 30(1):57-64. PubMed ID: 2513112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of human monocyte cytotoxicity by both interferon-gamma and -beta and comparison to other stimuli.
    Sharon N; Shoham J; Passwell JH
    Int J Immunopharmacol; 1989; 11(7):743-9. PubMed ID: 2513281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Sone S
    Jpn J Cancer Res; 1996 May; 87(5):497-504. PubMed ID: 8641987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma.
    Pujol JL; Gibney DJ; Su JQ; Maksymiuk AW; Jett JR
    J Natl Cancer Inst; 1993 Nov; 85(22):1844-50. PubMed ID: 8230265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.